Literature DB >> 19130305

The NAD World: a new systemic regulatory network for metabolism and aging--Sirt1, systemic NAD biosynthesis, and their importance.

Shin-Ichiro Imai1.   

Abstract

For the past several years, it has been demonstrated that the NAD-dependent protein deacetylase Sirt1 and nicotinamide phosphoribosyltransferase (Nampt)-mediated systemic NAD biosynthesis together play a critical role in the regulation of metabolism and possibly aging in mammals. Based on our recent studies on these two critical components, we have developed a hypothesis of a novel systemic regulatory network, named "NAD World", for mammalian aging. Conceptually, in the NAD World, systemic NAD biosynthesis mediated by intra- and extracellular Nampt functions as a driver that keeps up the pace of metabolism in multiple tissues/organs, and the NAD-dependent deacetylase Sirt1 serves as a universal mediator that executes metabolic effects in a tissue-dependent manner in response to changes in systemic NAD biosynthesis. This new concept of the NAD World provides important insights into a systemic regulatory mechanism that fundamentally connects metabolism and aging and also conveys the ideas of functional hierarchy and frailty for the regulation of metabolic robustness and aging in mammals.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19130305      PMCID: PMC2734380          DOI: 10.1007/s12013-008-9041-4

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  66 in total

1.  Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme.

Authors:  Tao Wang; Xiangbin Zhang; Poonam Bheda; Javier R Revollo; Shin-ichiro Imai; Cynthia Wolberger
Journal:  Nat Struct Mol Biol       Date:  2006-06-18       Impact factor: 15.369

Review 2.  The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals.

Authors:  Javier R Revollo; Andrew A Grimm; Shin-ichiro Imai
Journal:  Curr Opin Gastroenterol       Date:  2007-03       Impact factor: 3.287

3.  Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1.

Authors:  Joseph T Rodgers; Carlos Lerin; Wilhelm Haas; Steven P Gygi; Bruce M Spiegelman; Pere Puigserver
Journal:  Nature       Date:  2005-03-03       Impact factor: 49.962

Review 4.  A therapeutic role for sirtuins in diseases of aging?

Authors:  C H Westphal; M A Dipp; L Guarente
Journal:  Trends Biochem Sci       Date:  2007-11-05       Impact factor: 13.807

5.  The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control.

Authors:  Yasukazu Nakahata; Milota Kaluzova; Benedetto Grimaldi; Saurabh Sahar; Jun Hirayama; Danica Chen; Leonard P Guarente; Paolo Sassone-Corsi
Journal:  Cell       Date:  2008-07-25       Impact factor: 41.582

Review 6.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

7.  Decrease in glucose-stimulated insulin secretion with aging is independent of insulin action.

Authors:  Radhika Muzumdar; Xiaohui Ma; Gil Atzmon; Patricia Vuguin; Xiaoman Yang; Nir Barzilai
Journal:  Diabetes       Date:  2004-02       Impact factor: 9.461

Review 8.  Conserved metabolic regulatory functions of sirtuins.

Authors:  Bjoern Schwer; Eric Verdin
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

9.  Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells.

Authors:  Laura Bordone; Maria Carla Motta; Frederic Picard; Ashley Robinson; Ulupi S Jhala; Javier Apfeld; Thomas McDonagh; Madeleine Lemieux; Michael McBurney; Akos Szilvasi; Erin J Easlon; Su-Ju Lin; Leonard Guarente
Journal:  PLoS Biol       Date:  2005-12-27       Impact factor: 8.029

10.  SIRT1 deacetylates and positively regulates the nuclear receptor LXR.

Authors:  Xiaoling Li; Songwen Zhang; Gil Blander; Jeanette G Tse; Monty Krieger; Leonard Guarente
Journal:  Mol Cell       Date:  2007-10-12       Impact factor: 17.970

View more
  84 in total

1.  Nicotinamide Phosphoribosyltransferase in Human Diseases.

Authors:  Li Qin Zhang; Daniel P Heruth; Shui Qing Ye
Journal:  J Bioanal Biomed       Date:  2011-01-07

2.  Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 protein-mediated deacetylation.

Authors:  William C Hallows; Wei Yu; John M Denu
Journal:  J Biol Chem       Date:  2011-12-07       Impact factor: 5.157

3.  Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool.

Authors:  Maria Pittelli; Laura Formentini; Giuseppe Faraco; Andrea Lapucci; Elena Rapizzi; Francesca Cialdai; Giovanni Romano; Gloriano Moneti; Flavio Moroni; Alberto Chiarugi
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

Review 4.  The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing.

Authors:  S Imai; J Yoshino
Journal:  Diabetes Obes Metab       Date:  2013-09       Impact factor: 6.577

5.  Accurate measurement of nicotinamide adenine dinucleotide (NAD⁺) with high-performance liquid chromatography.

Authors:  Jun Yoshino; Shin-Ichiro Imai
Journal:  Methods Mol Biol       Date:  2013

Review 6.  "Clocks" in the NAD World: NAD as a metabolic oscillator for the regulation of metabolism and aging.

Authors:  Shin-Ichiro Imai
Journal:  Biochim Biophys Acta       Date:  2009-11-06

Review 7.  The role of mammalian sirtuins in the regulation of metabolism, aging, and longevity.

Authors:  Akiko Satoh; Liana Stein; Shin Imai
Journal:  Handb Exp Pharmacol       Date:  2011

8.  NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity.

Authors:  Sathisha Upparahalli Venkateshaiah; Sharmin Khan; Wen Ling; Rakesh Bam; Xin Li; Frits van Rhee; Saad Usmani; Bart Barlogie; Joshua Epstein; Shmuel Yaccoby
Journal:  Exp Hematol       Date:  2013-02-19       Impact factor: 3.084

Review 9.  A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis.

Authors:  Shin-Ichiro Imai
Journal:  Pharmacol Res       Date:  2010-01-18       Impact factor: 7.658

10.  Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1 and sirtuin 1.

Authors:  Weijing Cai; Maya Ramdas; Li Zhu; Xue Chen; Gary E Striker; Helen Vlassara
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.